225 related articles for article (PubMed ID: 16709023)
21. Clinical trials for glioblastoma multiforme using adenoviral vectors.
Wirth T; Samaranayake H; Pikkarainen J; Määttä AM; Ylä-Herttuala S
Curr Opin Mol Ther; 2009 Oct; 11(5):485-92. PubMed ID: 19806496
[TBL] [Abstract][Full Text] [Related]
22. Molecular advances of brain tumors in radiation oncology.
Noda SE; El-Jawahri A; Patel D; Lautenschlaeger T; Siedow M; Chakravarti A
Semin Radiat Oncol; 2009 Jul; 19(3):171-8. PubMed ID: 19464632
[TBL] [Abstract][Full Text] [Related]
23. Gene therapy of glioblastoma multiforme via combined expression of suicide and cytokine genes: a pilot study in humans.
Palù G; Cavaggioni A; Calvi P; Franchin E; Pizzato M; Boschetto R; Parolin C; Chilosi M; Ferrini S; Zanusso A; Colombo F
Gene Ther; 1999 Mar; 6(3):330-7. PubMed ID: 10435083
[TBL] [Abstract][Full Text] [Related]
24. Virus combinations and chemotherapy for the treatment of human cancers.
Kumar S; Gao L; Yeagy B; Reid T
Curr Opin Mol Ther; 2008 Aug; 10(4):371-9. PubMed ID: 18683102
[TBL] [Abstract][Full Text] [Related]
25. Natural and genetically engineered viral agents for oncolysis and gene therapy of human cancers.
Sinkovics JG; Horvath JC
Arch Immunol Ther Exp (Warsz); 2008 Dec; 56 Suppl 1():3s-59s. PubMed ID: 19104757
[TBL] [Abstract][Full Text] [Related]
26. [Oncolytic viruses in the therapy of gliomas].
Gubanova NV; Gaĭtan AS; Razumov IA; Mordvinov VA; Krivoshapkin AL; Netesov SV; Chumakov PM
Mol Biol (Mosk); 2012; 46(6):874-86. PubMed ID: 23350233
[TBL] [Abstract][Full Text] [Related]
27. A new recombinant vaccinia with targeted deletion of three viral genes: its safety and efficacy as an oncolytic virus.
Yang S; Guo ZS; O'Malley ME; Yin X; Zeh HJ; Bartlett DL
Gene Ther; 2007 Apr; 14(8):638-47. PubMed ID: 17268533
[TBL] [Abstract][Full Text] [Related]
28. Photochemical enhancement of gene delivery to glioblastoma cells is dependent on the vector applied.
Bonsted A; Høgset A; Hoover F; Berg K
Anticancer Res; 2005; 25(1A):291-7. PubMed ID: 15816550
[TBL] [Abstract][Full Text] [Related]
29. Gene therapy in the management of oral cancer: review of the literature.
Ayllón Barbellido S; Campo Trapero J; Cano Sánchez J; Perea García MA; Escudero Castaño N; Bascones Martínez A
Med Oral Patol Oral Cir Bucal; 2008 Jan; 13(1):E15-21. PubMed ID: 18167474
[TBL] [Abstract][Full Text] [Related]
30. Recent advances in therapy for glioblastoma.
Clarke J; Butowski N; Chang S
Arch Neurol; 2010 Mar; 67(3):279-83. PubMed ID: 20212224
[TBL] [Abstract][Full Text] [Related]
31. Targeted genetic and viral therapy for advanced head and neck cancers.
Huang PI; Chang JF; Kirn DH; Liu TC
Drug Discov Today; 2009 Jun; 14(11-12):570-8. PubMed ID: 19508919
[TBL] [Abstract][Full Text] [Related]
32. Generation of a recombinant oncolytic Newcastle disease virus and expression of a full IgG antibody from two transgenes.
Pühler F; Willuda J; Puhlmann J; Mumberg D; Römer-Oberdörfer A; Beier R
Gene Ther; 2008 Mar; 15(5):371-83. PubMed ID: 18200068
[TBL] [Abstract][Full Text] [Related]
33. Cure following gene therapy for recurrent glioblastoma multiforme?
Karabatsou K; Bernstein M
Acta Neurochir (Wien); 2008 Jun; 150(6):611-2. PubMed ID: 18511998
[TBL] [Abstract][Full Text] [Related]
34. Oncolytic HSV armed with platelet factor 4, an antiangiogenic agent, shows enhanced efficacy.
Liu TC; Zhang T; Fukuhara H; Kuroda T; Todo T; Martuza RL; Rabkin SD; Kurtz A
Mol Ther; 2006 Dec; 14(6):789-97. PubMed ID: 17045531
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic strategies for inhibiting invasion in glioblastoma.
Drappatz J; Norden AD; Wen PY
Expert Rev Neurother; 2009 Apr; 9(4):519-34. PubMed ID: 19344303
[TBL] [Abstract][Full Text] [Related]
36. [Oncolytic virus therapy for malignant brain tumors].
Ino Y; Todo T
Brain Nerve; 2009 Jul; 61(7):815-22. PubMed ID: 19618859
[TBL] [Abstract][Full Text] [Related]
37. [Using the thymidine kinase gene in therapy of solid tumors].
Wicke I; Gansbacher B
Internist (Berl); 1996 Apr; 37(4):369-73. PubMed ID: 8655273
[No Abstract] [Full Text] [Related]
38. Gene therapy of brain and endocrine tumors.
Palù G; Bonaguro R; Gnatta E; Franchin E; Barzon L
Croat Med J; 2001 Aug; 42(4):473-7. PubMed ID: 11471203
[TBL] [Abstract][Full Text] [Related]
39. Glioblastoma therapy: going beyond Hercules Columns.
Mangiola A; Anile C; Pompucci A; Capone G; Rigante L; De Bonis P
Expert Rev Neurother; 2010 Apr; 10(4):507-14. PubMed ID: 20367204
[TBL] [Abstract][Full Text] [Related]
40. Enhanced therapeutic efficacy of oncolytic herpes vector G207 against human non-small cell lung cancer--expression of an RNA-binding protein, Musashi1, as a marker for the tailored gene therapy.
Kanai R; Eguchi K; Takahashi M; Goldman S; Okano H; Kawase T; Yazaki T
J Gene Med; 2006 Nov; 8(11):1329-40. PubMed ID: 16955534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
